Pharmaceutical Technology

FEBRUARY 24, 2023

The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact.

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

Pharma Marketing Network

OCTOBER 31, 2023

Event marketing is a form of marketing that involves face-to-face interactions between a brand or product and potential customers. In the digital age, event marketing is becoming increasingly important for companies in the pharmaceutical industry. What is Event Marketing?

Marketing 52

Marketing Branding Production Pharma Companies 52

World of DTC Marketing

FEBRUARY 7, 2022

What has/is happening at Biogen is a train wreck, and the only way to correct this disaster is to tear it down and rebuild the company from the top down. ” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales). Click to Tweet.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

Outsourcing Pharma

MAY 23, 2024

A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.

Pharma Companies 52

Pharma Companies Drugs Medicine Development 52

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Capturing market share. billion by 2026, according to research by the Business Research Company.

Marketing 98

Marketing Life Science Sales Branding 98

pharmaphorum

APRIL 30, 2021

It’s fair to say this is the most interesting time ever for market access. Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks.

Marketing 81

Marketing Sales Regulation Pharma Companies 81

pharmaphorum

JANUARY 8, 2021

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications.

Marketing 75

Marketing Doctors Doctor Pharma Companies 75

World of DTC Marketing

OCTOBER 4, 2021

Earlier this year, I was asked by a client to write a position paper on using Facebook for the DTC marketing of an oncology product. A year ago, Facebook was making a hard charge to get the pharma business. TV will still be the first choice for many DTC marketers, but digital is increasing even though 50% of that money is wasted.

Branding 224

Branding Marketing Pharmacy Pharma Companies 224

World of DTC Marketing

MARCH 24, 2022

I’ve seen some new energy and thinking taking root in some big pharma companies. Still, I’m also seeing some recycled executives show up at other companies when they should have been removed permanently from the industry. John worked for a division of a major pharma company in Cambridge.

Pharma Companies 213

Pharma Companies HR Sales Regulation 213

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 105

Branding Marketing Pharma Companies Life Science 105

BioPharma Reporter

SEPTEMBER 30, 2020

The pandemic has required a rethink of how we do business: and CPhI Festival of Pharma is encouraging companies to prioritize sustainability efforts moving forward.

Pharma Companies 104

Pharma Companies Regulation Marketing 104

Pharmaceutical Technology

MARCH 30, 2023

The US FDA has revealed its detailed budget proposal for FY2024, which would require pharma companies to name their active pharmaceutical ingredient (API) suppliers, restart President Biden’s Cancer Moonshot, inject cash into amyotrophic lateral sclerosis (ALS) research, and enforce stricter rules around manufacturing, recalls, and shortages.

Contract Manufacturing 147

Contract Manufacturing Manufacturing Pharma Companies Cosmetics 147

Pharma Marketing Network

OCTOBER 12, 2023

Benefits of VR & AR in Pharma Advertising VR and AR offer a unique opportunity for pharma companies to engage with customers in a more immersive and interactive way. For example, by using VR and AR, a pharma company could create an interactive 3D environment that allows customers to explore the product in detail.

Pharma Companies 52

Pharma Companies Production Compliance Regulation 52

Pharma Marketing Network

OCTOBER 28, 2023

It is a shift from a traditional focus on drug development and marketing to a focus on the patient’s needs. This shift is being driven by advances in digital communication, which are allowing companies to better understand and meet the needs of their patients. What is Patient-Centricity?

Pharma Companies 52

Pharma Companies Marketing Development Sales 52

BioPharma Reporter

NOVEMBER 18, 2020

The COVID-19 pandemic is expected to continue to impose enormous burdens on societies and economies globally. While governments are now getting ready to ensure large-scale, equitable access and distribution of a COVID-19 vaccine, concern about vaccine hesitancy is growing worldwide.

Pharma Companies 66

Pharma Companies Vaccination Vaccine Regulation 66

Outsourcing Pharma

DECEMBER 12, 2023

Clinical-stage pharma company, PharmaKure which develops precision medicine for Alzheimerâs Disease and other neurological diseases has announced a collaboration agreement with one of the largest comprehensive universities in Malaysia.

Pharma Companies 98

Pharma Companies Medicine Development Regulation 98

Drug Discovery World

FEBRUARY 6, 2024

However, many have cautioned against too great a reliance on these tools and emphasised the importance of checks and balances to ensure the systems are properly regulated and results are verified. The use of AI is rapidly developing in society and as regulators we see more and more applications in the field of medicines.

Marketing 69

Marketing Medicine Genome Genomics 69

World of DTC Marketing

FEBRUARY 28, 2021

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7 billion in penalties. Ethical leadership!

Vaccination 180

Vaccination Vaccine Contamination Compliance 180

World of DTC Marketing

FEBRUARY 16, 2022

What is pharma’s responsibility? Pharma provides medications to treat everything from severe cardiac issues to depression but should America’s pharma companies go beyond just providing a treatment? People accuse pharma of keeping people sick to make money. Pha a fails in this. That’s a rumor.

Pharma Companies 178

Pharma Companies Regulation Vaccination Vaccine 178

Fossil Remedies

OCTOBER 16, 2022

When you launch a PCD pharma company , you have to do several preparations. In a pharma business, you have a distribution network like a pharma manufacturing company, pharma marketing company, C&F agents, wholesalers/distributors/stockiest, retailers, and pharmacies.

Licensing 52

Licensing Licensing Pharma Companies Cosmetics 52

BioPharma Reporter

AUGUST 31, 2023

The moment that major pharma companies have been dreading, since the approval of Biden's Inflation Reduction Act, has arrived.

Pharma Companies 97

Pharma Companies Drugs Regulation Marketing 97

BioPharma Reporter

FEBRUARY 2, 2021

Rows about vaccine supply and threats of export blocks donât do anything to bring us closer to ending the COVID-19 pandemic, say campaigners pushing for vaccine equity on a global level.

Pharma Companies 81

Pharma Companies Vaccination Vaccine Regulation 81

BioPharma Reporter

FEBRUARY 18, 2021

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

Pharma Companies 52

Pharma Companies Development Manufacturing Drugs 52

pharmaphorum

SEPTEMBER 15, 2022

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”

Dermatology 97

Dermatology Production Pharma Companies Marketing 97

pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors. It may also help the regulator to define target treatment populations better.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

BioPharma Reporter

JUNE 20, 2022

Following the adoption of a critical list of COVID-19 vaccines and treatments, European Union member states and pharma companies will communicate to ensure sufficient supply to meet evolving demand.

Pharma Companies 105

Pharma Companies Vaccination Vaccine Regulation 105

Outsourcing Pharma

FEBRUARY 7, 2022

The HIV-focused pharma company announced the agency has approved Cabenuva for administration as few as six times a year for adults living with the virus.

FDA Approval 111

FDA Approval Pharma Companies Regulation Marketing 111

pharmaphorum

SEPTEMBER 30, 2021

The new guidance is the first of a series that have been promised by the US regulator to develop a framework for regulating RWD, which is increasingly being used by pharma companies to investigate how their medicines perform beyond the controlled environment of clinical trials.

Pharma Companies 71

Pharma Companies Regulation Clinical Trials Clinical Trials 71

BioPharma Reporter

SEPTEMBER 19, 2023

The big pharma company Bristol Myers Squibb (BMS) has recruited contract manufacturing and development organization (CDMO) Samsung Biologics to manufacture a commercial antibody cancer treatment until 2030.

Manufacturing 59

Manufacturing Contract Manufacturing Pharma Companies Antibody 59

Delveinsight

AUGUST 17, 2020

The Gastroparesis market size in the 7MM was found to be USD 3,170.01 The poor diagnosis rate of the disease is another unmet need prevailing in the Gastroparesis market. However, for moderate-to-severe cases, medications exist in the gastroparesis market that proffers relief.

Marketing 54

Marketing FDA Approval Trials Clinical Development 54

BioPharma Reporter

OCTOBER 31, 2023

The London and New York-based gene therapy player MeiraGTx Holdings has received a $30 million investment from Sanofi in addition to potential strategic deals with the big pharma company down the road.

Gene Therapy 52

Gene Therapy Gene Pharma Companies Regulation 52

pharmaphorum

JULY 15, 2021

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma companies accused of colluding to hike the price of medicines delivered to the NHS. The regulator says that the in addition to the fines, the NHS may choose to pursue the companies for damages in the courts.

Marketing 119

Marketing Sales Pharma Companies Medicine 119

pharmaphorum

AUGUST 2, 2022

The current crop of approved PD-1/PD-L1 inhibitors headed by Merck & Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab) are all given IV , and have mainly jostled for market share based on their clinical indications. And BMS is also running late-stage trials of injectable Opdivo, so the race is on.

Trials 99

Trials Marketing Drugs Pharma Companies 99

Delveinsight

FEBRUARY 14, 2021

Pharmaceutical companies sell their orphan drugs at astronomical prices such that many patients are not able to afford them. Past years saw an increase in the entry of Orphan drugs in the market – at higher rates than ever before, and it is hurting the families and patients. Funding is an issue! A rare disease is a costly affair.

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52

BioPharma Reporter

MARCH 23, 2021

The pharma company and the CDC are recommending that adults continue routine vaccination during the COVID-19 pandemic to reduce future vaccine-preventable disease (VPD) outbreaks and overall strain on the healthcare system.

Vaccination 105

Vaccination Vaccine Pharma Companies Regulation 105

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home.

Marketing 105

Marketing Drugs Regulation Development 105

pharmaphorum

AUGUST 21, 2020

Here we highlight the biggest R&D, market access and digital coronavirus news of the past week. Pfizer and BioNTech have said their COVID-19 vaccine could be ready for regulators to review by October and approved by the end of the year after releasing more favourable data from an early-stage trial.

Vaccination 103

Vaccination Vaccine Regulation Manufacturing 103